Both in Biotechnology
Kalaris Therapeutics vs Cognition Therapeutics
Over the past year KLRS returned −59.2% and CGTX returned −60.1%; their daily moves had a correlation of 0.13.
KLRS −59.2% CGTX −60.1%Growth of $1, one year, split-adjusted
| Metric | KLRS | CGTX |
|---|---|---|
| Price | $2.00 | $0.7298 |
| Market cap | $47.6M | $69.4M |
| Today | −8.68% | −0.38% |
| 1 month | −36.7% | −31.2% |
| 6 months | −68.4% | −38.7% |
| Year to date | −76.3% | −45.9% |
| 1 year | −59.4% | −60.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $93.5M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 59.2% | 52.5% |
| Short % of float | 5.9% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).